United States · FDA National Drug Code directory
GLYRX-PF
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51754-6013_442634f7-9858-421d-91db-5bfdb21dcf13
- Product NDC
- 51754-6013
- Form
- INJECTION, SOLUTION
- Composition / generic term
- glycopyrrolate
- Labeler
- Exela Pharma Sciences, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200601
- Source listing expiry
- 20261231
Source-listed ingredients
- GLYCOPYRROLATE — .2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, PLASTIC in 1 CARTON (51754-6013-3) / 3 mL in 1 SYRINGE, PLASTIC · 51754-6013-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →